FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286209443> ?p ?o ?g. }

• W4286209443 abstract "National guidelines on transplant selection have adopted successful downstaging to within Milan criteria (MC) as a viable option for the treatment of hepatocellular carcinoma (HCC) before liver transplant (LT). Recurrence of HCC after LT carries a poor prognosis, and treatment modalities remain challenging.To establish the 10-year outcomes of patients with HCC after LT in a large, multicenter US study based on individual data; provide robust data on the long-term role of downstaging; and evaluate the association of treatment modalities with postrecurrence survival.In this cohort study, a retrospective, multicenter analysis of prospectively collected data was conducted for 2645 adults who had undergone LT for HCC at 5 US academic centers between January 2001 and December 2015. The analysis was performed from May 2019 through June 2021. Outcomes of 341 patients whose disease was downstaged to within MC were compared with those in 2122 patients whose disease was always within MC and 182 patients whose disease was not downstaged. The associations of tumor and treatment factors on postrecurrence survival were analyzed using Cox proportional hazards regression and multivariable logistic regression models.The primary outcome was overall survival for the whole cohort and according to downstaging status. Secondary outcomes were time to recurrence, recurrence-free survival, and recurrence after specific post-LT therapies.Of the 2645 patients studied, the median age was 59.9 years (IQR, 54.7-64.7 years). The majority of the patients were men (2028 [76.7%] vs 617 [23.3%] women). The 10-year post-LT survival and recurrence rates were, respectively, 52.1% and 20.6% among those whose disease was downstaged; 61.5% and 13.3% in those always within MC; and 43.3% and 41.1% in those whose disease was not downstaged. Independent variables associated with downstaging failure were tumor size greater than 7 cm at diagnosis (OR, 2.62; 95% CI, 1.20-5.75; P = .02), more than 3 tumors at diagnosis (OR, 2.34; 95% CI, 1.22-4.50; P = .01), and α-fetoprotein response of at least 20 ng/mL with less than 50% improvement from maximum α-fetoprotein before LT (OR, 1.99; 95% CI, 1.14-3.46; P = .02). Surgically treated patients with recurrent HCC differed in clinicopathologic characteristics and had improved 5-year postrecurrence survival rates (31.6% vs 7.3%; P < .001).In a large, multicenter cohort of patients with HCC successfully downstaged to within MC, 10-year post-LT outcomes were excellent, validating national downstaging policies and showing a clear utility benefit for LT prioritization decision making. Surgical management of HCC recurrence after LT was associated with improved survival in well-selected patients and should be pursued, if feasible." @default.
• W4286209443 created "2022-07-21" @default.
• W4286209443 creator A5000946629 @default.
• W4286209443 creator A5001521096 @default.
• W4286209443 creator A5003777210 @default.
• W4286209443 creator A5012272573 @default.
• W4286209443 creator A5012600570 @default.
• W4286209443 creator A5020775945 @default.
• W4286209443 creator A5020853710 @default.
• W4286209443 creator A5029954428 @default.
• W4286209443 creator A5033735284 @default.
• W4286209443 creator A5034600404 @default.
• W4286209443 creator A5045775714 @default.
• W4286209443 creator A5055139672 @default.
• W4286209443 creator A5071639584 @default.
• W4286209443 creator A5075909338 @default.
• W4286209443 creator A5082082558 @default.
• W4286209443 creator A5088285096 @default.
• W4286209443 creator A5091130570 @default.
• W4286209443 date "2022-07-20" @default.
• W4286209443 modified "2023-10-01" @default.
• W4286209443 title "Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma" @default.
• W4286209443 cites W1881850874 @default.
• W4286209443 cites W1899043322 @default.
• W4286209443 cites W1982906652 @default.
• W4286209443 cites W1990499032 @default.
• W4286209443 cites W2005041705 @default.
• W4286209443 cites W2008423320 @default.
• W4286209443 cites W2017549476 @default.
• W4286209443 cites W2021299297 @default.
• W4286209443 cites W2059377623 @default.
• W4286209443 cites W2077345541 @default.
• W4286209443 cites W2118698732 @default.
• W4286209443 cites W2161689638 @default.
• W4286209443 cites W2217529397 @default.
• W4286209443 cites W2277004004 @default.
• W4286209443 cites W2315027248 @default.
• W4286209443 cites W2473903189 @default.
• W4286209443 cites W2516740959 @default.
• W4286209443 cites W2603017800 @default.
• W4286209443 cites W2760934854 @default.
• W4286209443 cites W2770041126 @default.
• W4286209443 cites W2796067155 @default.
• W4286209443 cites W2883179872 @default.
• W4286209443 cites W2896531953 @default.
• W4286209443 cites W2909459536 @default.
• W4286209443 cites W2928244330 @default.
• W4286209443 cites W3038091633 @default.
• W4286209443 cites W3184850586 @default.
• W4286209443 cites W4211183069 @default.
• W4286209443 cites W4230740336 @default.
• W4286209443 cites W4232396777 @default.
• W4286209443 cites W4232620598 @default.
• W4286209443 cites W4235695814 @default.
• W4286209443 cites W4240656667 @default.
• W4286209443 cites W4244881153 @default.
• W4286209443 cites W4245899154 @default.
• W4286209443 cites W4249117446 @default.
• W4286209443 cites W4253784087 @default.
• W4286209443 doi "https://doi.org/10.1001/jamasurg.2022.2800" @default.
• W4286209443 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35857294" @default.
• W4286209443 hasPublicationYear "2022" @default.
• W4286209443 type Work @default.
• W4286209443 citedByCount "13" @default.
• W4286209443 countsByYear W42862094432022 @default.
• W4286209443 countsByYear W42862094432023 @default.
• W4286209443 crossrefType "journal-article" @default.
• W4286209443 hasAuthorship W4286209443A5000946629 @default.
• W4286209443 hasAuthorship W4286209443A5001521096 @default.
• W4286209443 hasAuthorship W4286209443A5003777210 @default.
• W4286209443 hasAuthorship W4286209443A5012272573 @default.
• W4286209443 hasAuthorship W4286209443A5012600570 @default.
• W4286209443 hasAuthorship W4286209443A5020775945 @default.
• W4286209443 hasAuthorship W4286209443A5020853710 @default.
• W4286209443 hasAuthorship W4286209443A5029954428 @default.
• W4286209443 hasAuthorship W4286209443A5033735284 @default.
• W4286209443 hasAuthorship W4286209443A5034600404 @default.
• W4286209443 hasAuthorship W4286209443A5045775714 @default.
• W4286209443 hasAuthorship W4286209443A5055139672 @default.
• W4286209443 hasAuthorship W4286209443A5071639584 @default.
• W4286209443 hasAuthorship W4286209443A5075909338 @default.
• W4286209443 hasAuthorship W4286209443A5082082558 @default.
• W4286209443 hasAuthorship W4286209443A5088285096 @default.
• W4286209443 hasAuthorship W4286209443A5091130570 @default.
• W4286209443 hasBestOaLocation W42862094431 @default.
• W4286209443 hasConcept C126322002 @default.
• W4286209443 hasConcept C141071460 @default.
• W4286209443 hasConcept C143998085 @default.
• W4286209443 hasConcept C151956035 @default.
• W4286209443 hasConcept C167135981 @default.
• W4286209443 hasConcept C2776282453 @default.
• W4286209443 hasConcept C2777075537 @default.
• W4286209443 hasConcept C2778019345 @default.
• W4286209443 hasConcept C2779609443 @default.
• W4286209443 hasConcept C2911091166 @default.
• W4286209443 hasConcept C50382708 @default.
• W4286209443 hasConcept C71924100 @default.
• W4286209443 hasConcept C72563966 @default.
• W4286209443 hasConceptScore W4286209443C126322002 @default.
• W4286209443 hasConceptScore W4286209443C141071460 @default.

• next